Trial Profile
A p53 basket trial of COTI-2 in patients with solid tumours
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 21 Mar 2017
Price :
$35
*
At a glance
- Drugs COTI 2 (Primary)
- Indications Colorectal cancer; Lung cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 21 Mar 2017 New trial record
- 16 Mar 2017 According to a Critical Outcome Technologies media relaese, dosing in this trial is expected to begin in the second half of 2017.